Drug Safety Executive Council:: Safer Medicines. Faster.

Featured Event

Jun

Cambridge Healthtech Institute's co-located conferences, Predicting Drug-Induced Cardiotoxicity and Tackling Drug-Induced Idiosyncratic Hepatotoxicity, cover the use of in vitro, in vivo and in silico tools for early prediction and detection of drug-induced adverse events.

View All

Quick Poll

How many new technology evaluations did your organization conduct in 2011?

1-3
4-10
11-20
20+

Latest Blog Post

DSEC... Open for Business!

By DSECCommunity Manager on 3/15/2012 11:35:15 AM

March 26, 2012

Dawn Van Dam, General Manager, Cambridge Healthtech Associates : If you are finding us for the first time… welcome. Our vision is for the Drug Safety Executive Council online community to become the platform to both network with peers and exchange ideas related to advancing drug safety solutions. Up until now, membership in the DSEC community has been limited to bio-pharma company employees. To engage a wider audience in the drug safety space, the new DSEC will include members from bio-pharma, along with governmental agencies, academia, CROs and technology providers.

I invite you to take a look around the new site, and we welcome your feedback.

Recent Discussions

CROs in GLP tox studies
In vitro studies in regulatory decision-making
in the news -- Using zebrafish model for research

All Discussions

Our Advisory Board

Featured Member

John Burkhardt

John Burkhardt, DVM, PhD
Global Head, Preclinical Safety, Abbott Laboratories

View all Advisory Board members